Role of melatonin in reduction of lipid peroxidation and peroxynitrite formation in non-septic shock induced by zymosan

Shock

Volumn 12, Issue 5, 1999, Pages 402-408

  El Sokkary, Gamal H ^a   Reiter, Russel J ^a   Cuzzocrea, Salvator ^c   Caputi, Achille P ^c   Hassanein, Abdel Fattah M M ^b   Tan, Dun Xian ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Assiut University   (Egypt)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 3-NITROTYROSINE; ANTIOXIDANT; DRUG DERIVATIVE; MALONALDEHYDE; MELATONIN; NITRATE; PEROXYNITRIC ACID; TYROSINE; ZYMOSAN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; EXUDATE; IMMUNOHISTOCHEMISTRY; KIDNEY; LIPID PEROXIDATION; LIVER; LUNG; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; SHOCK; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; EXUDATES AND TRANSUDATES; IMMUNOHISTOCHEMISTRY; KIDNEY; LIPID PEROXIDATION; LIVER; LUNG; MALE; MALONDIALDEHYDE; MELATONIN; NITRATES; RATS; RATS, SPRAGUE-DAWLEY; SHOCK; TYROSINE; ZYMOSAN;

EID: 0033227020     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199911000-00009     Document Type: Article

References (39)

1. Teixeria TJ, Williams PG, Hellewell PG: Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. J Pharmacol 110:416-422, 1993.
2. Decamp M, Demling R: Post-traumatic multi-system organ failure. JAMA 260:530-534, 1988.
3. Halliwell B: Oxidants and human disease: some new concepts. FASEB J. 1:358-364, 1987.
4. Szabo C, Zingarelli B, O'Conner M, Salzman AL: DNA strand breakage and activation of poly (ADP-ribose) synthetase and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 93:1753-1958, 1996.
5. Cuzzocrea S, Zingarelli B, Sautebin L, Rizzo A, Grisafulli C, Campo GM, Costantino G, Calapai G, Nava F, Di Rosa M, Caputi AP: Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock 8:268-275, 1997.
6. Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL, Caputi AP, Szabó C: Role of peroxynitrite and activation of poly(ADP-ribose) synthetase in the vascular failure induced by zymosan-activated plasma. Br J Pharmacol 122:493-503, 1997.
7. Cuzzocrea S, Zingarelli B, Caputi AP: Peroxynitrite-mediated DNA strand breakage activates poly(ADP-ribose) synthetase and causes cellular energy depletion in a nonseptic shock model induced by zymosan in the rat. Shock 9:336-340, 1998.
8. Reiter RJ: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 9:526-533, 1995.
9. Reiter RJ: Oxygen radical detoxification processes during aging: the functional importance of melatonin. Aging Clin Exp Res 7:340-351, 1995.
10. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ: Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine J 1:57-60, 1993.
11. Stasica P, Ulanski P, Rosiak JM: Melatonin as a hydroxyl radical scavenger. J Pineal Res 25:565-572, 1998.
12. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55:PL271-PL276, 1994.
13. Marshall KA, Reiter RJ, Poeggeler B, Aruoma OI, Halliwell B: Evaluation of the antioxidant activity of melatonin in vitro. Free Rad Biol Med 21: 307-315, 1996.
14. Reiter RJ, Tang L, Garcia JJ, Munoz-Hoyos A: Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 60:2255-2271, 1997.
15. Cuzzocrea S, Zingarelli B, Caputi AP: Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J Pineal Res 25:24-33, 1998.
16. Noda Y, Mori A, Liburty R, Packer L: Melatonin and its precursors scavenge nitric acid. J Pineal Res (in press).
17. Reiter RJ, Tang L, Garcia JJ, Muñoz-Hoyos A: Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 60:2255-2271, 1997.
18. Reiter RJ: Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56:359-384, 1998.
19. De La Lastra CA, Cabeza J, Motilva V, Martin MF: Melatonin protects against gastric ischemia-reperfusion in rats. J Pineal Res 23:47-52, 1997.
20. Li ZR, Reiter RJ, Fujimori O, Oh CS, Duan YP: Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin. J Pineal Res 22:117-123, 1997.
21. Princ FG, Juknat AA, Maxit AG, Cardalda C, Batlle A: Melatonin's antioxidant protection against β-aminolevulinic acid-induced oxidative damage in rat cerebellum. J Pineal Res 23:40-46, 1997.
22. Tan DX, Reiter RJ, Chen LD, Poeggeler B, Manchester LC, Barlow-Walden LR: Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by carcinogen safrole. Carcinogenesis 15:215-218, 1994.
23. Vijayalaxmi, Reiter RJ, Herman TS, Meltz ML: Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes. Mutat Res 397:203-208, 1998.
24. Bradford M: Rapid and sensitive method for quantification of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
25. Demling R, Daryani R, Campbell C, Knox J, Youn Y, Lalonde C: The effect of acute nonbacterial dependent peritonitis on lung and liver oxidant stress and antioxidant activity. Surgery 114:571-578, 1993.
26. Von Asmuth EJU, Maessen IG, Van der Linden CJ, Buurman WA: Tumor necrosis factor alpha (TNFα) and interleukin 6 in zymosan-induced shock model. Scand J Immunol 32:313-319, 1990.
27. Mainous MR, Tao P, Berg RD, Deitch EA: Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation. Arch Surg 126:33-37, 1991.
28. Tribble D, Au TK, Jones D: The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology 7:377-387, 1987.
29. LaLonde C, Demling RH, Goad MP: Tissue inflammation without bacteria produces increased oxygen consumption and distant organ lipid peroxidation. Surgery 104:49-56, 1988.
30. Otamiri T, Tagesson C: Role of phospholipase A2 and oxygenated free radicals in mucosal damage after small intestine and reperfusion. Am J Surg 157:562-566, 1989.
31. Salim AS: The significance of removing oxygen-derived free radicals in the treatment of acute and chronic duodenal ulceration in the rat. J Pharm Pharmacol 42:64-67, 1990.
32. Shah SV: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35:1093-1106, 1989.
33. Tan DX, Manchester LC, Reiter RJ, Plummer BF, Hardies LJ, Weintraub ST, Vijaylaxmi, Shepherd AMM: A novel melatonin metabolite, cyclic 3-hydroxymelatonin: A biomaker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 253:614-620, 1998.
34. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabó C: Protective effect of melatonin in carrageenan-induced models of local inflammation. J Pineal Res 23:106-116, 1997.
35. Barlow Walden LR, Reiter RJ, Abe M, Pablos M, Menendez-Pelaez A, Chen LD, Poeggler B: Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 26:497-504, 1995.
36. Pablos MI, Agapito MI, Gutierrez R, Recio JM, Reiter RJ, Barlow-Walden L, Acuñ-Castroviejo D, Menendez-Pelaez A: Melatonin stimulates the activity of the detoxifying glutathione peroxidase in several tissues of chicks. J Pineal Res 19:111-115, 1995.
37. Nava F, Calapai G, Facciola G, Cuzzocrea S, Giuliani G, De Sarro A, Caputi AP: Melatonin effects on inhibition of thirst and fever induced by lipopolysaccharide in rat. Eur J Pharmacol 331:267-274, 1997.
38. Lissoni P, Pittalis S, Ardizzoia A, Brivio F, Barni S, Tancini G, Pelizzoni F, Maestroni GJ, Zubelewicz B, Braczkowski R: Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin. Suppl Care Cancer 4:313-316, 1996.
39. Menendez-Pelaez A, Reiter RJ: Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J Pineal Res 15:56-69, 1993.